Birgitte Jacky

Birgitte Jacky

Auto-generated profile, based on publicly available information

Birgitte Jacky

Allergan Aesthetics, an AbbVie Company, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in bioRxiv
Verified
Preprint
Open access
NJNicholas G. James
Nicholas G. James
SMShiazah Malik
Shiazah Malik
BSBethany J. Sanstrum
Bethany J. Sanstrum
CRCatherine Rheaume
Catherine Rheaume
RBRon S. Broide
Ron S. Broide
BJBirgitte Jacky
Birgitte Jacky
Clostridium botulinum neurotoxin serotype A (BoNT/A) is a potent neurotoxin that also serves as an effective therapeutic for a variety of neuromuscular and glandular diseases and disorders. The observed pharmacological effect of BoNT/A is due to specific targeting and entry into motor nerve terminals within muscles followed by cleavage of the SNARE protein, SNAP-25, inducing a block in neurotransmission and temporary muscular paralysis. Specific binding and internalization of BoNT/A into neuronal cells are mediated by its binding domain (H C /A), which binds to GT1b ganglioside and protein cell surface receptors. Previously, fibroblast growth factor receptor 3 (FGFR3) was identified as a BoNT/A receptor, in addition to synaptic vesicle protein (SV2). To further study BoNT/A interactions with FGFRs, an FCS & TIRF receptor dimerization assay was developed to measure dimerization of FGFRs in live cells, as FGFR dimerization can be considered an indirect measure for receptor-ligand binding interaction and downstream signaling. The ability of H C /A to facilitate dimerization of three FGFR subtypes (FGFR1-3) was assessed. Recombinant H C /A (rH C /A) was shown to dimerize FGFR subtypes in the rank order FGFR3c > FGFR2b > FGFR1c. With potencies (EC 50 values) defined as the concentration of ligand required to dimerize 50% of the receptors, wild type rH C /A dimerized FGFR3c with an EC 50 of 24 nM, similar to FGF9, a native FGFR3c ligand, which had an EC 50 of 15 nM, while FGFR1c and FGFR2b required higher rH C /A concentrations (≥100 nM and 68 nM, respectively). Furthermore, addition of the GT1b ganglioside to the culture media resulted in increased dimerization, whereas a ganglioside mutant variant of H C /A (rH C /A W1266L;Y1267S) showed decreased dimerization. Interestingly, reduced dimerization was also observed with an SV2 mutant variant of H C/ A (rH C /A T1145A;T1146A). These results support a model wherein BoNT/A interacts with FGFRs, gangliosides, and SV2 on the cell surface to facilitate cell uptake.

1 January 2021 in Toxicon
Verified
Journal Article
Closed access
DRDavid Rupp
David Rupp
DCDavid Canty
David Canty
CRCatherine Rheaume
Catherine Rheaume
BJBirgitte Jacky
Birgitte Jacky
RBRon Shraga Broide
Ron Shraga Broide
ABAmy Brideau-Andersen
Amy Brideau-Andersen